Sector report · September 2026
Healthcare: September 2026 sector report
Composed from 13 research facts recorded in September 2026, drawn from 9 source documents. Every figure names the record it came from and the date that record speaks for.
In brief
No narrative: no language model answered (All LLM providers failed. Please check API configurations.). No narrative is printed for this report. The figures and the facts below are complete without it.
Sector multiple
EV to EBITDA: 8.1x to 14.8x, median 11.0x. Our own estimate, worked out by MANDA Institute (Q1 2026). Nobody publishes this figure. Source: MANDA Institute sector estimate (MANDA Institute), as of 31 March 2026.
Eurozone all sector anchor, for context: median 8.6x, range 7.8x to 10.0x. An independent firm published this figure: the Argos Mid-Market Index, from Argos Wityu / Epsilon Research (Q1 2026). Source: Argos Mid-Market Index, as of 31 March 2026.
Transaction records
0 approved by a reviewer and 4 awaiting review. No figure from an unapproved record is printed.
financing: 4 facts
- Tandem Health scores $100M Series B, led by EU’s €5bn tech startup fund (Tech.eu - European Startup, Funding and Technology News)
- Tandem Health scores $100M Series B, led by EU’s €5bn tech startup fund (Tech.eu - European Startup, Funding and Technology News)
- €160K raised by PANDA Therapeutics (Tech.eu - European Startup, Funding and Technology News)
- €2M raised by Holifya (Tech.eu - European Startup, Funding and Technology News)
regulatory: 4 facts
- UK seals free trade agreement with Switzerland including GBP 5.2bn services deal and separate agreement for travellers to use Swiss E-gates (Wirtschaftsnachrichten | Wirtschafts-News | Handelsblatt)
- Germany as a business location under pressure according to Pharma Deutschland industry association (Sustainability and ESG)
- UK targets services exports in China trade talks (Wirtschaftsnachrichten | Wirtschafts-News | Handelsblatt)
- Germany as a business location under pressure according to 'Pharma Deutschland' (BDO Talks Total Tax Podcast)
competitor move: 3 facts
- AstraZeneca's breast cancer pill fails in decisive study (Tech.eu - European Startup, Funding and Technology News)
- Boehringer Ingelheim successfully attracts executives to Ingelheim, retaining them long-term through special programs (Statistical calendars)
- Boehringer Ingelheim successfully attracts executives to Ingelheim with special programs (Wirtschaftsnachrichten | Wirtschafts-News | Handelsblatt)
deal volume: 2 facts
- Eli Lilly strengthens immunology business with billion-euro acquisition (Tech.eu - European Startup, Funding and Technology News)
- Eli Lilly strengthens immunology business with billion-euro acquisition (Wirtschaftsnachrichten | Wirtschafts-News | Handelsblatt)
Records this report rests on
- Our own estimate, worked out by MANDA Institute (Q1 2026). Nobody publishes this figure. (31 March 2026)
- An independent firm published this figure: the Argos Mid-Market Index, from Argos Wityu / Epsilon Research (Q1 2026) (31 March 2026)
- Tech.eu - European Startup, Funding and Technology News
- Tech.eu - European Startup, Funding and Technology News
- Wirtschaftsnachrichten | Wirtschafts-News | Handelsblatt
- Sustainability and ESG
- BDO Talks Total Tax Podcast
- Statistical calendars
- Wirtschaftsnachrichten | Wirtschafts-News | Handelsblatt
- Tech.eu - European Startup, Funding and Technology News
- Wirtschaftsnachrichten | Wirtschafts-News | Handelsblatt